UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Ambulatory ECG monitoring

Author
Philip J Podrid, MD, FACC
Section Editor
Peter J Zimetbaum, MD
Deputy Editor
Brian C Downey, MD, FACC

INTRODUCTION

In contrast to the standard electrocardiogram (ECG), which provides a fixed picture of cardiac electrical activity over a brief duration, ambulatory ECG monitoring provides a view of electrocardiographic data over an extended period of time, thereby permitting evaluation of dynamic cardiac electrical phenomena that are often transient and of brief duration. The most common ambulatory ECG application is in the diagnosis and assessment of cardiac arrhythmias or conduction abnormalities (symptomatic or asymptomatic) or the presence of potential arrhythmias (such as in patients with syncope or presyncope), but ambulatory ECG also has a role in the assessment of prognosis and risk stratification of various cardiac populations, in the evaluation of arrhythmia therapy, and for the evaluation of silent ischemia. (See "Clinical features and treatment of ventricular arrhythmias during acute myocardial infarction" and "Silent myocardial ischemia: Epidemiology, pathophysiology, and diagnosis" and "Evaluation of heart rate variability".)

Ambulatory ECG monitoring, which can be performed using a variety of techniques for as short as 24 to 48 hours and for as long as months to years, offers the opportunity to review cardiac ECG data during normal routine activity, including any physical and psychological stresses. Ambulatory ECG monitoring for longer periods (when compared with standard ECG for a 10-second time period) is more sensitive for detecting spontaneous, often highly variable cardiac arrhythmias or conduction abnormalities [1,2].

Ambulatory monitoring, in conjunction with clinical and electrocardiographic findings, can be a useful component of the evaluation of the patient with unexplained syncope, presyncope, or palpitations. A detailed discussion of the evaluation of syncope and palpitations, including the role of ambulatory monitors, is presented separately. (See "Syncope in adults: Clinical manifestations and diagnostic evaluation" and "Overview of palpitations in adults".)

INDICATIONS

Ambulatory ECG monitoring is the most widely employed technology to evaluate a patient with symptoms suggestive of a cardiac arrhythmia or a conduction abnormality. The 1999 American College of Cardiology/American Heart Association (ACC/AHA) guidelines on ambulatory electrocardiography recommended only two indications for this approach [3]:

Unexplained syncope, near syncope, or episodic dizziness (see "Syncope in adults: Clinical manifestations and diagnostic evaluation")

               

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Fri Jan 22 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Boudoulas H, Schaal SF, Lewis RP, Robinson JL. Superiority of 24-hour outpatient monitoring over multi-stage exercise testing for the evaluation of syncope. J Electrocardiol 1979; 12:103.
  2. Poblete PF, Kennedy HL, Caralis DG. Detection of ventricular ectopy in patients with coronary heart disease and normal subjects by exercise testing and ambulatory electrocardiography. Chest 1978; 74:402.
  3. Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the guidelines for ambulatory electrocardiography). Circulation 1999; 100:886.
  4. Afzal MR, Gunda S, Waheed S, et al. Role of Outpatient Cardiac Rhythm Monitoring in Cryptogenic Stroke: A Systematic Review and Meta-Analysis. Pacing Clin Electrophysiol 2015; 38:1236.
  5. Barry J, Campbell S, Nabel EG, et al. Ambulatory monitoring of the digitized electrocardiogram for detection and early warning of transient myocardial ischemia in angina pectoris. Am J Cardiol 1987; 60:483.
  6. Joshi AK, Kowey PR, Prystowsky EN, et al. First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmia. Am J Cardiol 2005; 95:878.
  7. Olson JA, Fouts AM, Padanilam BJ, Prystowsky EN. Utility of mobile cardiac outpatient telemetry for the diagnosis of palpitations, presyncope, syncope, and the assessment of therapy efficacy. J Cardiovasc Electrophysiol 2007; 18:473.
  8. Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general clinical practice. Ann Intern Med 1999; 130:848.
  9. Krahn AD, Klein GJ, Skanes AC, Yee R. Insertable loop recorder use for detection of intermittent arrhythmias. Pacing Clin Electrophysiol 2004; 27:657.
  10. Giada F, Gulizia M, Francese M, et al. Recurrent unexplained palpitations (RUP) study comparison of implantable loop recorder versus conventional diagnostic strategy. J Am Coll Cardiol 2007; 49:1951.
  11. Pürerfellner H, Sanders P, Pokushalov E, et al. Miniaturized Reveal LINQ insertable cardiac monitoring system: First-in-human experience. Heart Rhythm 2015; 12:1113.
  12. Furukawa T, Maggi R, Bertolone C, et al. Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope. J Cardiovasc Electrophysiol 2012; 23:67.
  13. Mittal S, Sanders P, Pokushalov E, et al. Safety Profile of a Miniaturized Insertable Cardiac Monitor: Results from Two Prospective Trials. Pacing Clin Electrophysiol 2015; 38:1464.
  14. Zeldis SM, Levine BJ, Michelson EL, Morganroth J. Cardiovascular complaints. Correlation with cardiac arrhythmias on 24-hour electrocardiographic monitoring. Chest 1980; 78:456.
  15. Gibson TC, Heitzman MR. Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope. Am J Cardiol 1984; 53:1013.
  16. Bass EB, Curtiss EI, Arena VC, et al. The duration of Holter monitoring in patients with syncope. Is 24 hours enough? Arch Intern Med 1990; 150:1073.
  17. Surawicz B, Pinto RP. Symptoms in hospital patients and outpatients with ventricular arrhythmias during ambulatory ECG monitoring. J Ambul Monit 1991; 4:83.
  18. Nwasokwa ON, Wenger NK. Diagnostic value of ambulatory electrocardiography: Dependence on presenting symptom, age and sex. Am J Noninvasive Cardiol 1988; 2:140.
  19. Krahn AD, Klein GJ, Fitzpatrick A, et al. Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring. Pacing Clin Electrophysiol 2002; 25:37.
  20. Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 2001; 104:46.
  21. Krahn AD, Klein GJ, Yee R, et al. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation 1999; 99:406.
  22. Farwell DJ, Freemantle N, Sulke AN. Use of implantable loop recorders in the diagnosis and management of syncope. Eur Heart J 2004; 25:1257.
  23. Brignole M, Sutton R, Menozzi C, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 2006; 27:1085.
  24. Edvardsson N, Frykman V, van Mechelen R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace 2011; 13:262.